1-180916587-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000367588.9(KIAA1614):c.484G>T(p.Ala162Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000784 in 1,606,598 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000367588.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIAA1614 | NM_020950.2 | c.484G>T | p.Ala162Ser | missense_variant | 2/9 | ENST00000367588.9 | NP_066001.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIAA1614 | ENST00000367588.9 | c.484G>T | p.Ala162Ser | missense_variant | 2/9 | 1 | NM_020950.2 | ENSP00000356560 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000127 AC: 31AN: 243860Hom.: 0 AF XY: 0.000151 AC XY: 20AN XY: 132522
GnomAD4 exome AF: 0.0000832 AC: 121AN: 1454380Hom.: 2 Cov.: 36 AF XY: 0.000101 AC XY: 73AN XY: 722556
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2023 | The c.484G>T (p.A162S) alteration is located in exon 2 (coding exon 2) of the KIAA1614 gene. This alteration results from a G to T substitution at nucleotide position 484, causing the alanine (A) at amino acid position 162 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at